Tuesday, May 29th, 2018
FOR IMMEDIATE RELEASE
Hocoma officially launches its new sensor-based stroke therapy solution with Saebo’s innovative mobile arm support.
CHARLOTTE, NC AND VOLKETSWIL, SWITZERLAND – Tuesday, May 29th, 2018
Hocoma is pleased to announce the formal launch of the ArmeoSenso, a sensor-based solution for patients with mild to moderate impairments of the upper extremity. The ArmeoSenso completes Hocoma’s modular Armeo Therapy Concept for all stages of arm and hand function recovery by allowing patients to extend their treatment beyond the clinic walls: Thanks to its easy-to-use interface and its light-weight and compact design, patients can continue to make progress in the comfort of their own home.
“We are very excited to officially put the ArmeoSenso on the market,” said Hocoma CEO Dr. Gery Colombo. “I am convinced that our new device will offer patients with arm and hand impairments a very versatile and affordable rehabilitation solution to improve their abilities. These benefits will make all the time and effort our team invested in developing the ArmeoSenso and acquiring the different registrations and certifications worthwhile.”
The ArmeoSenso comprises three sensors –two for the arm and one for the chest–, a hand module, and a software program with game-like exercises that provide highly intensive yet motivating therapy. Optionally, the ArmeoSenso can be ordered with the SaeboMAS mini, a table-mounted system for patients who cannot fully support the weight of their arm on their own. “We partnered with Saebo in July 2017,” Colombo added. “Together, we plan to develop further solutions that complement each other as perfectly as the SaeboMAS mini and the ArmeoSenso.”
Hocoma is accepting orders for the ArmeoSenso. Shipping costs and delivery times depend on the region in which the order was placed. Prospective buyers should consult the account manager for their region for details.
Chief Creative Officer
+41 43 444 23 65
Successful therapy begins in the patient’s mind. Firmly believing that they can reach their goals, one step at a time. The Swiss medical technology company Hocoma is committed to successful therapy. Its innovative technologies and ideas lend functional movement therapy new impetus, promote autonomous therapy, and provide for maximal motivation. In the rehabilitation technology field, Hocoma is internationally recognized as a pioneer and market leader. As a Total Solution Provider, we cover the entire continuum of rehabilitation: Our portfolio includes robotic and sensor-based medical devices for early rehabilitation and mobilization, for intensive gait therapy, for arm and hand function recovery, and for lower back pain relief. Additionally, our support packages offer a helping hand with clinical integration and research, business design, financing options, and marketing, and our technical support hotline is available 24/7. Hocoma founder and CEO Dr. Gery Colombo believes: “Those who break new ground must be open-minded towards unusual methods.” We have been living this mission statement since our beginnings in 1996 – at our headquarters in Switzerland as well as our subsidiaries in Chile, Singapore, Slovenia, and the USA. All the while, ideal therapy remains our primary goal. Hocoma has been a proud partner of DIH International and Motek since August 2016. The company belongs to the DIH Rehabilitation Division which collectively generated a 50 million USD turnover in 2017.
For more information about Hocoma, please visit www.hocoma.com.
Saebo, Inc. is a medical device company primarily engaged in the discovery, development, and commercialization of affordable and novel clinical solutions designed to improve mobility and function in individuals suffering from neurological and orthopedic conditions. With a vast network of Saebo-trained clinicians spanning six continents, Saebo has helped over 250,000 clients around the globe achieve a new level of independence.
For more information about Saebo, please visit www.www.saebo.com.
All Hocoma products are medical devices and must be used in strict adherence to the User Manual; failure to do so may result in serious personal injury. It is strongly recommended that you regularly consult Hocoma’s website (www.hocoma.com/legalnotes) for the latest available information. Please contact Hocoma in case of any questions.
Use only under the supervision of qualified medical personnel. However, certain Hocoma products are marketed for home use and must be strictly used according to the recommendations of your medical care provider who is knowledgeable about your specific needs. Consult the User Manual and Hocoma’s website (www.hocoma.com/legalnotes) for appropriate product designation. Failure to obtain and follow the recommendations of your medical care provider may result in serious personal injury.
This information provides details about medical products which may not be available in all countries and may not have received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing herein should be construed as a solicitation or promotion of any product or of an indication of any specific use for any product which is not authorized by the laws and regulations of the country where the reader of this information resides.